BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 24, 2022
View Archived Issues
LBX2 is a marker of colon adenocarcinoma
Read More
Endonuclease V is a diagnostic and prognostic marker in colon adenocarcinoma
Read More
CDK9 inhibition as promising therapeutic strategy against HCC
Read More
Chinese researchers patent sigma-1 receptor agonists
Read More
Sichuan Haisco Pharmaceutical discloses new JAK inhibitors
Read More
Immunophage Biomedical presents new CCR8 antagonists
Read More
Shanghai Institute of Materia Medica identifies new S1PR1 agonists
Read More
Inventisbio Shanghai discloses GTPase KRAS mutant inhibitors
Read More
New approach integrates CAR-T cell immunotherapy with local activation of small-molecule prodrugs
Read More
Engineered virus-like particles for in vivo delivery of gene editing proteins
Read More
Oasmia advances its next-generation XR-18 drug delivery technology
Read More
IM-1761065, a novel biguanide with promising activity in models of glioblastoma
Read More
HS6ST2 predicts survival in PDAC
Read More
Anti-ANXA1 antibody MDX-124 shows promise in preclinical models of pancreatic cancer
Read More
Sorrento's STI-9167 neutralizes Omicron and Omicron (+R346k) variants of SARS-CoV-2
Read More
TACH-101 shows activity in gastric and colorectal cancer models
Read More
Small molecule improves AD neuropathology in mice
Read More
Juva Life advances JUVA-041 into preclinical development
Read More